The medication is approved for treatment of recently-diagnosed low-risk adults with acute promyelocytic leukemia (APL).
A cure for leukemia may lie in an innovative and targeted form of stem cell treatment currently being developed in Israel.
Israeli scientists at Ben Gurion University of the Negev have reached a breakthrough in HIV and leukemia research.
The U.S. Food and Drug Administration (FDA) has granted Israeli-based Teva Pharmaceuticals full approval for Synribo, a drug that is injected for adults with...
"Over his entire brief but meaningful life, Sammy has taught all of us about courage, struggle, strength, and wisdom."
Printed from: http://www.jewishpress.com/news/us-news/fda-approves-teva-leukemia-treatment/2018/01/15/
Scan this QR code to visit this page online: